TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CapsoVision, Inc. ( (CV) ) has shared an update.
On September 22, 2025, CapsoVision, Inc. announced the planned retirement of Rebecca Petersen, its Senior Director of Clinical Affairs, effective October 15, 2025. Keri Jorgenson has been promoted to Director of Clinical Operations and will lead the clinical development operations, ensuring a seamless transition. Petersen will continue to support the company through a consulting agreement starting October 16, 2025, to facilitate a smooth transition without disrupting operations.
The most recent analyst rating on (CV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on CapsoVision, Inc. stock, see the CV Stock Forecast page.
More about CapsoVision, Inc.
Average Trading Volume: 247,173
Learn more about CV stock on TipRanks’ Stock Analysis page.